A clinical scoring system for congenital contractural arachnodactyly

Article metrics

Abstract

Purpose

Congenital contractural arachnodactyly (CCA) is an autosomal dominant connective tissue disorder manifesting joint contractures, arachnodactyly, crumpled ears, and kyphoscoliosis as main features. Due to its rarity, rather aspecific clinical presentation, and overlap with other conditions including Marfan syndrome, the diagnosis is challenging, but important for prognosis and clinical management. CCA is caused by pathogenic variants in FBN2, encoding fibrillin-2, but locus heterogeneity has been suggested. We designed a clinical scoring system and diagnostic criteria to support the diagnostic process and guide molecular genetic testing.

Methods

In this retrospective study, we assessed 167 probands referred for FBN2 analysis and classified them into a FBN2-positive (n = 44) and FBN2-negative group (n = 123) following molecular analysis. We developed a 20-point weighted clinical scoring system based on the prevalence of ten main clinical characteristics of CCA in both groups.

Results

The total score was significantly different between the groups (P < 0.001) and was indicative for classifying patients into unlikely CCA (total score <7) and likely CCA (total score ≥7) groups.

Conclusions

Our clinical score is helpful for clinical guidance for patients suspected to have CCA, and provides a quantitative tool for phenotyping in research settings.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Fig. 1
Fig. 2
Fig. 3

References

  1. 1.

    Hecht F, Beals RK. “New” syndrome of congenital contractural arachnodactyly originally described by Marfan in 1896. Pediatrics. 1972;49:574–579.

  2. 2.

    Ramos Arroyo MA, Weaver DD, Beals RK. Congenital contractural arachnodactyly. Report of four additional families and review of literature. Clin Genet. 1985;27:570–581.

  3. 3.

    Viljoen D. Congenital contractural arachnodactyly (Beals syndrome). J Med Genet. 1994;31:640–643.

  4. 4.

    Gupta PA, Putnam EA, Carmical SG, et al. Ten novel FBN2 mutations in congenital contractural arachnodactyly: delineation of the molecular pathogenesis and clinical phenotype. Hum Mutat. 2002;19:39–48.

  5. 5.

    Callewaert BL, Loeys BL, Ficcadenti A, et al. Comprehensive clinical and molecular assessment of 32 probands with congenital contractural arachnodactyly: report of 14 novel mutations and review of the literature. Hum Mutat. 2009;30:334–341.

  6. 6.

    Bamshad M, Jorde LB, Carey JC. A revised and extended classification of the distal arthrogryposes. Am J Med Genet. 1996;65:277–281.

  7. 7.

    Macnab AJ, D’Orsogna L, Cole DE, et al. Cardiac anomalies complicating congenital contractural arachnodactyly. Arch Dis Child. 1991;66:1143–1146.

  8. 8.

    Gupta PA, Wallis DD, Chin TO, et al. FBN2 mutation associated with manifestations of Marfan syndrome and congenital contractural arachnodactyly. J Med Genet. 2004;41:e56.

  9. 9.

    Takeda N, Morita H, Fujita D, et al. Congenital contractural arachnodactyly complicated with aortic dilatation and dissection: case report and review of literature. Am J Med Genet A. 2015;167a:2382–2387.

  10. 10.

    Anderson RA, Koch S, Camerini-Otero RD. Cardiovascular findings in congenital contractural arachnodactyly: report of an affected kindred. Am J Med Genet. 1984;18:265–271.

  11. 11.

    Bell RE, Wheller JJ. Cardiac defects in a patient with congenital contractural arachnodactyly. South Med J. 1985;78:742–743.

  12. 12.

    Huggon IC, Burke JP, Talbot JF. Contractural arachnodactyly with mitral regurgitation and iridodonesis. Arch Dis Child. 1990;65:317–319.

  13. 13.

    Su PH, Hou JW, Hwu WL, et al. Congenital contractural arachnodactyly (Beals syndrome). Acta Paediatr Taiwan. 2000;41:59–62.

  14. 14.

    Bass HN, Sparkes RS, Crandall BF, Marcy SM. Congenital contractural arachnodactyly, keratoconus, and probable Marfan syndrome in the same pedigree. J Pediatr. 1981;98:591–593.

  15. 15.

    Bawle E, Quigg MH. Ectopia lentis and aortic root dilatation in congenital contractural arachnodactyly. Am J Med Genet. 1992;42:19–21.

  16. 16.

    Tuncbilek E, Alanay Y. Congenital contractural arachnodactyly (Beals syndrome). Orphanet J Rare Dis. 2006;1:20.

  17. 17.

    Dietz HC, Cutting GR, Pyeritz RE, et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature. 1991;352:337–339.

  18. 18.

    Lee B, Godfrey M, Vitale E, et al. Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes. Nature. 1991;352:330–334.

  19. 19.

    Putnam EA, Zhang H, Ramirez F, Milewicz DM. Fibrillin-2 (FBN2) mutations result in the Marfan-like disorder, congenital contractural arachnodactyly. Nat Genet. 1995;11:456–458.

  20. 20.

    Putnam EA, Cho M, Zinn AB, et al. Delineation of the Marfan phenotype associated with mutations in exons 23-32 of the FBN1 gene. Am J Med Genet. 1996;62:233–242.

  21. 21.

    Park ES, Putnam EA, Chitayat D, et al. Clustering of FBN2 mutations in patients with congenital contractural arachnodactyly indicates an important role of the domains encoded by exons 24 through 34 during human development. Am J Med Genet. 1998;78:350–355.

  22. 22.

    Robinson PN, Godfrey M. The molecular genetics of Marfan syndrome and related microfibrillopathies. J Med Genet. 2000;37:9–25.

  23. 23.

    Faivre L, Collod-Beroud G, Loeys BL, et al. Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study. Am J Hum Genet. 2007;81:454–466.

  24. 24.

    Faivre L, Collod-Beroud G, Callewaert B, et al. Clinical and mutation-type analysis from an international series of 198 probands with a pathogenic FBN1 exons 24-32 mutation. Eur J Hum Genet. 2009;17:491–501.

  25. 25.

    Nishimura A, Sakai H, Ikegawa S, et al. FBN2, FBN1, TGFBR1, and TGFBR2 analyses in congenital contractural arachnodactyly. Am J Med Genet A. 2007;143a:694–698.

  26. 26.

    Kircher M, Witten DM, Jain P, et al. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet. 2014;46:310–315.

  27. 27.

    Menten B, Buysse K, Vandesompele J, et al. Identification of an unbalanced X-autosome translocation by array CGH in a boy with a syndromic form of chondrodysplasia punctata brachytelephalangic type. Eur J Med Genet. 2005;48:301–309.

  28. 28.

    Sante T, Vergult S, Volders PJ, et al. ViVar: a comprehensive platform for the analysis and visualization of structural genomic variation. PLoS ONE. 2014;9:e113800.

  29. 29.

    Steinbrook R. Guidance for guidelines. N Engl J Med. 2007;356:331–333.

  30. 30.

    Milewicz DM, Pyeritz RE, Crawford ES, Byers PH. Marfan syndrome: defective synthesis, secretion, and extracellular matrix formation of fibrillin by cultured dermal fibroblasts. J Clin Invest. 1992;89:79–86.

  31. 31.

    Dietz HC, McIntosh I, Sakai LY, et al. Four novel FBN1 mutations: significance for mutant transcript level and EGF-like domain calcium binding in the pathogenesis of Marfan syndrome. Genomics. 1993;17:468–475.

  32. 32.

    Eldadah ZA, Brenn T, Furthmayr H, Dietz HC. Expression of a mutant human fibrillin allele upon a normal human or murine genetic background recapitulates a Marfan cellular phenotype. J Clin Invest. 1995;95:874–880.

  33. 33.

    Dietz HC, Pyeritz RE. Mutations in the human gene for fibrillin-1 (FBN1) in the Marfan syndrome and related disorders. Hum Mol Genet. 1995;4:1799–1809.

  34. 34.

    Milewicz DM, Urban Z, Boyd C. Genetic disorders of the elastic fiber system. Matrix Biol. 2000;19:471–480.

  35. 35.

    Judge DP, Biery NJ, Keene DR, et al. Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome. J Clin Invest. 2004;114:172–181.

  36. 36.

    Dietz HC, Loeys B, Carta L, Ramirez F. Recent progress towards a molecular understanding of Marfan syndrome. Am J Med Genet C Semin Med Genet. 2005;139c:4–9.

  37. 37.

    Renard M, Francis C, Ghosh R, et al. Clinical validity of genes for heritable thoracic aortic aneurysm and dissection. J Am Coll Cardiol. 2018;72:605–615.

Download references

Acknowledgements

B.C. is a senior clinical investigator funded by Fund for Scientific Research Flanders (FWO). This project was funded by the Special Research foundation of Ghent University to B.C. (starting grant BOFSTA2016002401) and to A.D.P. (Methusalem grant BOF15/MET-V/011). We thank Jan C. Oosterwijk and Rebecca Igbokwe for their helpful comments on the manuscript. We are grateful to all patients and their families for their interest and participation.

Author information

Correspondence to Bert Callewaert MD, PhD.

Ethics declarations

Disclosure

The authors declare no conflicts of interest.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Meerschaut, I., De Coninck, S., Steyaert, W. et al. A clinical scoring system for congenital contractural arachnodactyly. Genet Med (2019) doi:10.1038/s41436-019-0609-8

Download citation

Keywords

  • congenital contractural arachnodactyly
  • Beals syndrome
  • fibrillin-2
  • clinical score
  • diagnostic criteria